Physician

Michael Kevin O'Donoghue, M.D.

According to 2025 Medicare claims, Michael O'Donoghue, M.D. (NPI: 1194748962) practices dermatology in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is ILLINOIS DERMATOLOGY INSTITUTE, LLC (NPI: 1891920898; TIN: 26-3341995) and primary practice location at 46360-7125.

O'Donoghue's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,794 traditional Medicare patients, billed 23,041 HCPCS/CPT codes, and received $323,984 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,796 prescription claims across 723 beneficiaries totaling $859,974 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 175 records totaling $32,571. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $317,332 and ending at $323,984. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $237,413 to $859,974. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,749	10,425	$317,332
2016	1,836	10,972	$396,897
2017	1,651	9,855	$286,577
2018	1,369	17,164	$236,670
2019	1,406	22,182	$250,152
2020	1,362	16,031	$219,101
2021	1,485	20,026	$276,163
2022	1,848	25,515	$311,945
2023	1,698	23,327	$266,996
2024	1,794	23,041	$323,984

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	537	1,514	$237,413
2016	508	1,310	$221,065
2017	497	1,413	$333,578
2018	489	1,403	$394,062
2019	516	1,442	$411,785
2020	547	1,644	$482,229
2021	675	1,777	$594,654
2022	668	1,743	$807,779
2023	655	1,523	$1,100,975
2024	723	1,796	$859,974

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	227	244	$64
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,219	1,709	$59
17000	Destruction of precancer skin growth, 1 growth	1,052	1,422	$40
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	580	712	$33
17003	Destruction of precancer skin growth, 2-14 growths	804	4,570	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	25	700	$175,005
Otezla	Apremilast	26	778	$127,513
Cosentyx Sensoready (2 Pens)	Secukinumab	11	308	$80,242
Dupixent Pen	Dupilumab	15	392	$56,041
Fluorouracil	Fluorouracil	85	2,437	$6,672

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	175	$32,571	Galderma Laboratories, L.P.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Kevin O'Donoghue, M.D.?

Tedicare shows public-source Medicare data for Michael Kevin O'Donoghue, M.D. (NPI 1194748962), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Kevin O'Donoghue, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Kevin O'Donoghue, M.D.?

Michael Kevin O'Donoghue, M.D. is linked to ILLINOIS DERMATOLOGY INSTITUTE, LLC (billing NPI 1891920898) in the available physician profile data.

Does Michael Kevin O'Donoghue, M.D. have Open Payments data?

Michael Kevin O'Donoghue, M.D. has 175 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.